Teleflex Incorporated (NYSE:TFX) Receives $139.00 Consensus Target Price from Analysts

Shares of Teleflex Incorporated (NYSE:TFX) have received an average rating of “Hold” from the nine brokerages that are covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $140.7143.

TFX has been the subject of several research analyst reports. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Wall Street Zen cut Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Needham & Company LLC increased their target price on Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a research note on Thursday. Truist Financial raised their target price on shares of Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a report on Thursday, December 18th. Finally, Wells Fargo & Company upped their price target on shares of Teleflex from $116.00 to $130.00 and gave the company an “equal weight” rating in a report on Friday.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Teleflex by 57.9% during the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock worth $26,000 after buying an additional 77 shares during the last quarter. Banque Cantonale Vaudoise increased its position in shares of Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after purchasing an additional 113 shares during the last quarter. Hantz Financial Services Inc. raised its stake in shares of Teleflex by 40.5% during the 4th quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company’s stock worth $48,000 after purchasing an additional 113 shares in the last quarter. UMB Bank n.a. boosted its holdings in shares of Teleflex by 57.1% in the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after buying an additional 113 shares during the last quarter. Finally, Maryland State Retirement & Pension System boosted its holdings in shares of Teleflex by 1.5% in the 4th quarter. Maryland State Retirement & Pension System now owns 8,652 shares of the medical technology company’s stock valued at $1,056,000 after buying an additional 129 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Performance

TFX stock opened at $121.95 on Monday. The company has a quick ratio of 2.01, a current ratio of 2.54 and a debt-to-equity ratio of 0.81. Teleflex has a twelve month low of $100.18 and a twelve month high of $143.32. The business’s fifty day moving average is $111.34 and its 200-day moving average is $118.68. The company has a market cap of $5.39 billion, a P/E ratio of -5.93, a price-to-earnings-growth ratio of 3.74 and a beta of 0.87.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, February 26th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.73 by ($1.80). The company had revenue of $569.00 million for the quarter, compared to the consensus estimate of $912.57 million. Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.Teleflex’s quarterly revenue was down 28.5% on a year-over-year basis. During the same quarter last year, the business posted $3.89 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities research analysts forecast that Teleflex will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 6th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. Teleflex’s dividend payout ratio is -6.62%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.